Nuclear EGFR impairs ASPP2-p53 complex-induced apoptosis by inducing SOS1 expression in hepatocellular carcinoma
Kai Liu1,2, Tao Jiang1, Yabo Ouyang1,2
1Beijing You'an Hospital, Capital Medical University, Beijing, 100069, China.
Abstract:
ASPP2 can bind to p53 and enhance the apoptotic capabilities of p53 by guiding it to the promoters of pro-apoptotic genes. Here, ASPP2 overexpression for 24 hours transiently induced apoptosis in hepatoma cells by enhancing the transactivation of p53 on pro-apoptotic gene promoters. However, long-term ASPP2 overexpression (more than 48 hours) failed to induce apoptosis because p53 was released from the pro-apoptotic gene promoters. In non-apoptotic cells, nuclear EGFR induced SOS1 expression by directly binding to the SOS1 promoter. SOS1 activated the HRAS/PI3K/AKT pathway and resulted in nuclear translocation of p-AKT and Bcl-2. The interaction between p-AKT and ASPP2 facilitates Bcl-2 binding to p53, which releases p53 from the pro-apoptotic gene promoters. The in vivo assay demonstrated that EGFR/SOS1-promoted growth of nuclear p-AKT+, Bcl-2+ cells results in the resistance of hepatoma cells to ASPP2-p53 complex-induced apoptosis and that blocking nuclear translocation of EGFR dramatically improves and enhances the pro-apoptotic function of ASPP2. Finally, the activation of the HRAS/PI3K/AKT pathway by EGFR-induced SOS1 also inhibits cisplatin-induced apoptosis, suggesting a common apoptosis-evasion mechanism in hepatoma cells. Because evasion of apoptosis contributes to treatment resistance in hepatoma, our results also support further investigation of combined therapeutic blockade of EGFR and SOS1.
Insights
ASPP2 induces apoptosis in hepatoma cells by enhancing p53
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Death Pathways
Background:
- Apoptosis evasion is a hallmark of cancer, contributing to treatment resistance in hepatoma.
- ASPP2 (Apoptosis-Stimulating Protein of p53) interacts with p53 to promote apoptosis.
- EGFR signaling can influence cell survival pathways.
Purpose of the Study:
- To elucidate the mechanism by which ASPP2 regulates apoptosis in hepatoma cells.
- To investigate the role of EGFR and downstream pathways in modulating ASPP2-induced apoptosis.
- To identify potential therapeutic targets for overcoming apoptosis resistance in hepatoma.
Main Methods:
- Transient and long-term overexpression of ASPP2 in hepatoma cells.
- Analysis of p53 binding to pro-apoptotic gene promoters.
- Investigating the EGFR/SOS1/HRAS/PI3K/AKT pathway activation.
- In vivo assays to assess tumor growth and apoptosis resistance.
- Blocking nuclear EGFR translocation.
Main Results:
- Short-term ASPP2 overexpression enhanced p53-mediated apoptosis.
- Long-term ASPP2 overexpression led to apoptosis resistance due to p53 release.
- EGFR signaling via SOS1 activates AKT, promoting Bcl-2 interaction with p53.
- Blocking EGFR nuclear translocation restored ASPP2's pro-apoptotic function.
- EGFR/SOS1 pathway activation confers resistance to cisplatin-induced apoptosis.
Conclusions:
- EGFR signaling promotes hepatoma cell survival by inhibiting ASPP2-p53 complex-induced apoptosis.
- The EGFR/SOS1/AKT/Bcl-2 axis represents a common mechanism of apoptosis evasion in hepatoma.
- Combined blockade of EGFR and SOS1 may represent a viable therapeutic strategy for hepatoma treatment.
More Related Videos
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
13:34A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
Related Concept Videos
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Regulation of Nuclear Protein Sorting
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
